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Abstract 
Objective: To derive cluster analysis‑based groupings for adults with congenital heart disease (ACHD) when it comes 
to perceived health, psychological functioning, health behaviours and quality of life (QoL).
Methods: This study was part of a larger worldwide multicentre study called APPROACH‑IS; a cross sectional study 
which recruited 4028 patients (2013–2015) from 15 participating countries. A hierarchical cluster analysis was per‑
formed using Ward’s method in order to group patients with similar psychological characteristics, which were defined 
by taking into consideration the scores of the following tests: Sense Of Coherence, Health Behavior Scale (physical 
exercise score), Hospital Anxiety Depression Scale, Illness Perception Questionnaire, Satisfaction with Life Scale and 
the Visual Analogue Scale scores of the EQ‑5D perceived health scale and a linear analogue scale (0–100) measuring 
QoL.
Results: 3768 patients with complete data were divided into 3 clusters. The first and second clusters represented 
89.6% of patients in the analysis who reported a good health perception, QoL, psychological functioning and the 
greatest amount of exercise. Patients in the third cluster reported substantially lower scores in all PROs. This cluster 
was characterised by a significantly higher proportion of females, a higher average age the lowest education level, 
more complex forms of congenital heart disease and more medical comorbidities.
Conclusions: This study suggests that certain demographic and clinical characteristics may be linked to less favour‑
able health perception, quality of life, psychological functioning, and health behaviours in ACHD. This information 
may be used to improve psychosocial screening and the timely provision of psychosocial care.
Keywords: Cluster analysis, Adults with congenital heart disease, Perceived health, Psychological functioning, Health 
behaviours, Quality of life
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Introduction
Congenital heart disease (CHD) is the most common 
type of birth defect globally. Its prevalence has progres-
sively increased to 9.410/1000 in the period 2010–2017. 
Since most serious congenital heart defects can be oper-
ated on, over 90% of children with CHD now survive 
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into adulthood [1, 2]. The overall prevalence of CHD in 
the adult population has been estimated to be approxi-
mately 3000 per million [3]. In 2014 it had reached 60% 
of the total CHD population [4]. In those countries where 
there is improved survival, new challenges must be faced, 
as the CHD population continues to grow and age. These 
changing needs encompass, not only to ongoing and life-
long medical issues, for which only palliative rather than 
curative interventions are available but also difficulties 
encountered regarding psychosocial well-being [5]. In 
a recent scientific statement from the American Heart 
Association on the Diagnosis and Management of Non-
cardiac Complications in Adults with Congenital Heart 
Disease, it was observed that these patients are at an 
increased risk of psychological distress, neurocognitive 
impairment and social challenges. Furthermore it was 
recommended that they be screened for psychosocial 
issues and not only depression [6].
When it comes to perceived health in ACHD (meas-
ured with the EQ-5D) [7], there are indications that in 
this population, the findings are influenced by symptoms, 
NYHA-classification, age and gender and symptomatic 
patients reported a lower perceived health on EQ-VAS. 
In another study from Sweden also using the EQ-5D, 
worse self-reported health was associated with several 
medical and social factors; presence of cardiovascular 
symptoms, active smoking, history of valve surgery, low 
educational level, and higher systolic blood pressure. [8].
Psychiatric disorders, particularly mood and anxiety 
disturbances were significantly more frequent in ACHD 
compared to the general population, and lower cut off 
scores for the HADS should be utilised for screening pur-
poses [9]. It was also noted that quality of life was inde-
pendently and negatively associated with a diagnosis of 
major depression, alcohol dependency, nicotine depend-
ency and NYHA class.
Sense of coherence was reported to be higher in adults 
with CHD than the general population and was a strong 
predictor of life quality [10–12]. Independently from 
patient characteristics, poor illness perceptions (meas-
ured by the IPQ-R) were associated with lower quality of 
life [13].
In a study from Denmark, in which different cardiac 
populations were compared, including congenital heart 
disease, predictive factors for worse scores on perceived 
health status (Short Form-12 and EQ-5D), psychologi-
cal functioning (HADS), illness perception (Brief Illness 
Perception Questionnaire) and Qol (HeartQoL)  across 
diagnoses were female sex, older age, being unmarried, 
planned admission, longer hospital stay, and higher co-
morbidity score [14].
A recent extensive review contended that when it 
comes to quality of life (QoL) measured as life satisfaction 
(Ex. With the Satisfaction with Life Scale) it is generally 
good in patients with CHD and can be even better than 
healthy peers. However, when it is measured as physical 
functioning, patients with a complex condition do worse 
than those with a less serious condition or healthy indi-
viduals. Predictors of poor QoL were reported to be older 
age, being a job seeker, unemployed or disabled, never 
having married, worse functional status, perceived illness 
and religion and spirituality [15].
Some time ago, a cluster analysis was performed on a 
smaller sample of ACHD, who were categorised accord-
ing to their reported good, moderate or poor quality of 
life, as measured by a linear analogue scale [16]. In this 
study, most of the patients were found to have a good 
quality of life (three quarters). Poorer quality of life was 
associated with a lower educational level, unemployment 
or disability, associated syndromes, instability of the 
heart disease, and a poorer functional status.
The aim of the present study was to determine if and 
what phenotypes could potentially exist in this popula-
tion. In order to proceed with this, a hierarchical cluster 
analysis was performed taking into consideration both 
the primary outcomes (perceived health status, psycho-
logical functioning, health behaviours and QOL) and 
also the secondary outcomes (sense of coherence and 
illness perception), in order to identify if there are spe-
cific associated phenotypes based on sociodemographic 
and medical variables. A detailed description of primary 
and secondary outcomes is available in an earlier paper 
describing rationale, design and method of the study [17].
Method
An international collaborative research group was cre-
ated to further study patient reported outcomes in CHD. 
This study is part of a large study, entitled the Assessment 
of Patterns of Patient-Reported Outcomes in Adults 
with Congenital Heart disease-International Study 
(APPROACH-IS) conducted in partnership with the 
International Society for Adult Congenital Heart Disease 
(ISACHD).
APPROACH-IS was a cross sectional study in which 
data were collected from April 2013 to March 2015 from 
15 participating countries over 5 continents: Argentina, 
Australia, Belgium, Canada, France, India, Italy, Japan, 
Malta, Norway, Sweden, Switzerland, Taiwan, the Neth-
erlands, and the United States of America (USA) [17].
The study was approved by the institutional review 
board of the coordinating center (University Hospi-
tals Leuven/KU Leuven, Belgium) and complies with 
the Declaration of Helsinki. Local institutional board 
approval was requested and obtained when required. 
Written informed consent was obtained from all par-
ticipating patients. More detailed information about the 
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design, rationale and methods of APPROACH-IS is avail-
able in a methods paper [17] and the study protocol was 
recorded at ClinicalTrials.gov: NCT02150603. The cur-
rent analyses are part of a large project, and the details 
on the project and publications coming from this project 
so far can be found using the following link: http://www.
appro ach-is.net/thepr oject 1.html.
This work was supported by the Research Fund—KU 
Leuven (Leuven, Belgium) through grant OT/11/033 to 
K.L. and P.M.; by the Swedish Heart–Lung Foundation 
(Sweden)  through grant number 20130607 to M.D.; by 
the University of Gothenburg Centre for Person-cen-
tred Care (Gothenburg, Sweden) to M.D. and P.M.; and 
by the Cardiac Children’s Foundation (Taiwan) through 
grant CCF2013_02 to H.L.Y. Furthermore, this work was 
endorsed by and conducted in collaboration with the 
International Society for Adult Congenital Heart Dis-
ease. This study was also partially supported by Ricerca 
Corrente funding from the Italian Ministry of Health to 
IRCCS Policlinico San Donato. The authors have no com-
peting interests to declare.
Study population and procedure
Patients were required to be 18 years or older, diagnosed 
with CHD and with continuing follow-up and with the 
capacity to complete self-report questionnaires. More 
details on patient characteristics and information about 
the variance with respect to different countries can be 
obtained from previously published papers [18–20].
Measures
The psychometric tests utilised for the primary out-
comes can be grouped into four Patient Reported Out-
come (PRO) domains (1) perceived health status using 
the 12-item Short Form Health Survey [21] and the 
EuroQOL-5D Visual Analog Scale [22]; (2) psychologi-
cal functioning using the Hospital Anxiety and Depres-
sion Scale [23]; (3) amount of exercise per patient (based 
on the average time in hours, spent per week in various 
types of physical exercise) using a subscale of Health-
Behavior Scale–Congenital Heart Disease [24]; and (4) 
QoL using a Linear Analog Scale [25]; and the Satisfac-
tion With Life Scale [26].
In addition, two further tests were administered to 
assess secondary outcomes, the sense of coherence SOC-
13 [27] and the Illness Perception Questionnaire Brief 
IPQ [28]. More details about these measures and the 
interpretation of the various scores are available in our 
methodological paper.
For the purposes of the cluster analysis, one measure 
was selected per construct. For example, when it comes 
to perceived health, only the EuroQOL-5D Visual 
Analog Scale was utilised, further supported by EQ-5D 
validity, reliability and responsiveness previously con-
firmed in cardiovascular patients and SF-12 in medical 
populations. Some other dimensions of the SF12, such 
as the emotional components, are also covered by the 
inclusion of the other scales.
Statistical analysis
A hierarchical cluster analysis was performed by using 
Ward’s method in order to group patients with similar 
psychological characteristics, which were defined by 
taking into consideration scores of the following tests: 
SOC, HBS (physical exercise score), HADS (anxiety 
and depression subscales), IPQ, SWLS and the Visual 
Analogue Scale (VAS) scores of the EQ-5D perceived 
health scale and QoL quality of life.
Stability measure was then compared across clus-
tering methods and numbers of clusters to select the 
model associated with the most stable solution. Clus-
tering methods considered were the hierarchical Ward’s 
minimum variance, K-means and d K medians and 
number of clusters k varying from 2 to 4.
Moreover the number of clusters (k) considered was 
identified by using the following 3 indices:
1. Cubic clustering criterion (CCC),
2. Pseudo F (PSF),
3. T2 (PST2).
The hierarchical structure of the data was visualized 
using a dendogram created according to the Ward’s dis-
tance. Principal component analysis (PCA) was used 
to visualize the data for cluster analysis, to character-
ize the association among psychological tests and to 
plot together variables and subjects by using a biplot. 
The biplot was also used to visualize the clusters on 
two-dimensional plots. The convenience of using two-
dimensional plots comes at the expense of the loss of 
a certain amount of information on the association 
patterns.
Inferential statistical tests were used to evaluate the 
association between clusters and variables not used to 
determine the clusters. In particular, the chi‐square test 
was used to analyse the association of clusters and cat-
egorical variables (demographic and clinical character-
istics: gender, education state, cardiac severity and all 
patient reported outcomes) while the Kruskal–Wallis 
test was used to analyse the association with continuous 
parameters (age, number of cardiac surgeries, number of 
catheterisms). Results were considered statistically sig-
nificant at p < 0.05. Statistical analyses were performed 
using SAS software, version 9.4 (SAS Institute, Inc., Cary, 
NC) and with R software version 3.6.3.
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Results
The initial sample consisted in 4028 patients. 260 (6.5%) 
patients were not included in the data analysis due to 
missing data. A comparison of demographic and clini-
cal characteristics between those included and those 
not included in the analysis revealed no evidence of dif-
ference between the two groups of subjects (according 
to Chi-square or Fisher exact test) for all the variables, 
except for the education level (the percentage of gradu-
ates is about 31% for those included and 19% for those 
not included, while less than High School was 5% for 
those included and 14% among those not included, 
p < 0.001).
The remaining 3768 patients were divided into three 
clusters. The PCA analysis showed a positive correla-
tion between the EQ LAS scale and the QoL LAS and 
between the HADS anxiety and depression subscales. 
A negative correlation was observed between SOC and 
HADS anxiety subscale and between IPQ and EQ LAS. 
A low correlation was shown between SOC and SWLS 
score.
The distribution of patient scores in the various clus-
ters are reported in Table  1 and a visual representation 
of these scores can be seen in Fig.  1. Although a trend 
could be observed regarding physical activity in the vari-
ous clusters, the HBS (physical exercise score) was not 
strongly correlated with the results of the other question-
naires (Fig. 2).
Regardless of stability indices and number of clusters, 
more stable solutions were obtained with hierarchical 
Table 1 Patients score distribution in clusters
Data are presented as: mean ± standard deviation and (median, interquartile 
range) or n (%)
SOC Sense of Coherence, EQ EuroQol Numerical Rating Scale, HBS Health 
Behavior Scale, HADS Hospital Anxiety and Depression Scale (anx Anxiety, depr 
depression), IPQ Illness Perception Questionnaire, SWLS Satisfaction with Life 
Scale, QoL: Quality of Life Numerical Rating Scale
Cluster (mean ± std–median (25° percentile–75° 
percentile))
1 (N = 1783) 2 (N = 1595) 3 (N = 390)



















































Fig. 1 Visual representation of cluster scores
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Ward’s model. In addition, the most stable solution was 
obtained with 2 clusters but coefficient of 3 clusters were 
similar (hierarchical cluster 2: APN = 0.0009, AD = 40.26, 
ADM = 0.19, FOM = 10.06, Connectivity = 9.32, 
Dunn = 0.15 and Silhouette = 0.62 while cluster 3: 
APN = 0.0057, AD = 40.20, ADM = 0.46, FOM = 10.03, 
Connectivity = 9.32, Dunn = 0.15 and Silhouette = 0.60). 
Therefore, we decided to compute with a hierarchical 
algorithm and a predefined number of clusters equal to 3 
which included a large number of patients.
The first and second cluster represented 89.6% of 
patients in the analysis. Cluster 1, 2 and 3 included 1783, 
1595 and 390 patients (Fig.  3) respectively. When it 
comes to a Sense of Coherence and coping styles (SOC) 
in the first and second cluster, the patients reported 
above average scores (73.7 ± 9.0 and 60.7 ± 10.8 respec-
tively) whereas patients in the 3rd cluster reported scores 
that were generally in the average range (48.8 ± 12.0).
Fig. 2 Biplot of the  tests of the 3 patient clusters
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Finally, the Health Behaviour Scale (HBS) (physical 
exercise score) mean was 5.1 ± 9.6 for cluster 1, 2.8 ± 4.2 
for cluster 2 and 1.5 ± 1.7 for cluster 3. This indicates 
that the patients in the first cluster were more active 
physically, the ones in the second cluster were reasonably 
active, but less so than cluster 1, and the patients in the 
third cluster were the least active physically, when meas-
ured by number of hours of sports/physical activity per 
week. However, we have to remark, that even though the 
median HBS in the first cluster is higher than the other 
clusters, there is a large variability in the scores, indicat-
ing a degree of overlap with the other clusters.
The prevalence of males decreased through clusters 
(51.0% in cluster 1 vs 45.0% in cluster 2 vs 42.3% in clus-
ter 3, p < 0.0001) (Table 2). Patients in cluster 1 had signif-
icantly higher levels of education than patients in cluster 
3 (college and university 55.7% vs 53.4% vs 34.5%). The 
complexity of CHD varied significantly in the 3 clusters as 
follows: simple lesions in 29.1% vs 24.0% vs 19.7%; com-
plex lesions in 20.8% vs 28.0% vs 35.6% p < 0.0001). Cur-
rent congestive health failure increased significantly from 
cluster 1–3 (1.4% vs 4.1% vs 9.4% p < 0.0001) as well as the 
prevalence of a cardiac device (8.6% vs 13.4% vs 18.9% 
p < 0.0001). History of arrhythmia increased significantly 
from cluster 1 to 3 (22.8% vs 29.15 vs 42.4% p < 0.0001). 
The subgroups were statistically associated with the prev-
alence of admission in hospital for cardiac disease within 
the past year (13.5% vs 17.7% vs 30.5% p < 0.0001), with 
the number of cardiac surgeries (1.4 ± 1.3 vs 1.7 ± 1.5 
vs 1.0 ± 1.6 p < 0.0001) and number of catheterizations 
(0.6 ± 1.2 vs 0.9 ± 1.5 vs 1.0 ± 1.6 p < 0.0001). There was 
a significant difference in the prevalence of reported 
mood (cluster 1 2.9% vs cluster 2 6.5% vs cluster 3 20.4% 
p < 0.0001) and anxiety disorders (respectively 1.6% vs 
6.0% vs 13.6% p < 0.0001).
Data are presented as: mean ± standard deviation and 
(median, interquartile range) or n (%).
SOC Sense of Coherence, EQ EuroQol Numerical Rat-
ing Scale, HBS Health Behavior Scale, HADS Hospital 
Anxiety and Depression Scale (anx Anxiety, depr depres-
sion), IPQ Illness Perception Questionnaire, SWLS Sat-
isfaction with Life Scale, QoL: Quality of Life Numerical 
Rating Scale
Discussion
The ACHD population is a growing population with spe-
cific medical and psychosocial challenges. In order to 
address these needs, it is extremely important to iden-
tify factors associated with poorer outcomes. Although 
numerous studies have explored perceived health sta-
tus, psychological functioning, quality of life and health 
behaviours, different instruments were used, making it 
difficult to compare results in a large subset of patients. 
Most studies did not include a sufficiently large popula-
tion to conduct a cluster analysis, especially one that con-
siders the four domains selected in our study [17].
In the current analysis, identification of 3 clusters per-
mitted inclusion of the majority of patients (93.5%) with 
significant differences between all 3 of them. The first 
and second clusters included the majority of the study 
population with favourable PROs, with the first cluster 
reporting the best scores. A smaller portion of the study 
population i.e. 390/3768 (10.3%), had worse PRO in the 
various domains. In the following paragraphs we will 
discuss the various domains and compare them with the 
available studies using the same instruments.
Fig. 3 Single linkage clustering
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When it comes to perceived health, there have been 
contradictory results. As noted in the Introduction, per-
ceived health as measured by the EQ-5D was linked with 
the following; symptoms, NYHA, age and gender, pres-
ence of cardiovascular symptoms, active smoking, his-
tory of valve surgery, low educational level, and higher 
systolic blood pressure [7, 8].
Our study is in line with these results. First of all, 
results are consistent with other studies in which per-
ceived health is linked to quality of life. In the third 
cluster there was a substantial difference when it comes 
to the VAS scores in health perception. Consistent with 
previous studies, there are more females in this cluster, 
their average age is significantly higher, their education 
is significantly lower and there were significantly higher 
prevalence of congestive heart failure and arrhythmia. 
The  3rd cluster also had the largest percentage of complex 
heart disease and patients admitted to the hospital in the 
previous year, with the lowest physical exercise scores of 
the HBS.
The results in this study are also concordant with a 
study from Belgium on a smaller sample of ACHD [16]. 
Similar to our study, most patients were found to have 
a good quality of life (three quarters) Lower educational 
level, unemployment or disability, associated syndromes 
and functional cardiac outcomes were associated with 
poorer quality of life. The clustering of the patients also 
support the results on psychological functioning, where 
the HADS was utilised [9]. In the third cluster with the 
lowest quality of life scores, there was a much higher 
prevalence of mood and anxiety disorders, also reported 
by a significant difference in the HADS scores, where 
most of the patients reported a mild depression and a 
mild to moderate anxiety.
Table 2 Demographics and clinical characteristics of the clusters




 Simple 519 (29.1) 382 (24.0) 77 (19.7)
 Moderate 893 (50.1) 761 (47.7) 174 (44.6)
 Great 371 (20.8) 452 (28.3) 139 (35.6)
Gender 0.0002
 Male 905 (51.0) 715 (45.0) 164 (42.3)
Educ < 0.0001
 Less than high school 64 (3.6) 87 (5.5) 37 (9.5)
 High school 718 (40.7) 651 (41.2) 217 (55.9)
 College degree 380 (21.5) 373 (23.4) 53 (13.7)
 University degree 603 (34.2) 471 (29.8) 81 (20.9)
Congestive heart failure < 0.0001
 Never 1627 (92.8) 1375 (87.6) 299 (78.1)
 Past, not current 101 (5.8) 131 (8.3) 48 (12.5)
 Current 25 (1.4) 64 (4.1) 36 (9.4)
Cardiac device < 0.0001
 None 1391 (91.5) 1265 (86.6) 283 (81.1)
 ICD 45 (3.0) 57 (3.9) 18 (5.2)
 PM 85 (5.6) 139 (9.5) 48 (13.8)
History of arrhythmia 404 (22.9) 462 (29.1) 165 (42.5) < 0.0001
Cognitive impairment 16 (0.9) 23 (1.5) 4 (1.0) 0.33
Inpatient cardiac adm within past year 236 (13.5) 278 (17.7) 117 (30.5) < 0.0001
Mood disorder 52 (2.9) 103 (6.5) 79 (20.4) < 0.0001
Anxiety disorder 29 (1.6) 96 (6.0) 53 (13.6) < 0.0001
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As expected, when reviewing the secondary and 
explanatory variables, sense of coherence and illness 
perception, there was an important difference in the 
clusters. Patients in the third cluster had substantially 
a lower sense of coherence scores than the other 2 
clusters. They also reported the highest illness percep-
tion scores, indicating a more pessimistic view of their 
illness. With respect to these constructs, the results 
are in line with the previous studies in this population, 
suggesting links between a higher sense of coherence 
and better illness perception being associated with a 
better quality of life [3, 13].
It is interesting to note that all variables related to 
PROs are also interrelated except for the physical 
activity subscale of the Health Behaviors Scale. It is 
possible that carrying out a cluster analysis on such a 
large sample has helped to uncover associations which 
were not explored in previous studies. It may also be 
that the presence of various demographic, clinical and 
psychosocial variables in the same person can have a 
cumulative effect which in turn results in global wors-
ening of psychological functioning, which includes 
lower health perception, decreased quality of life and 
higher levels of anxiety and depression, and also an 
absence of those protective variables such a sense of 
coherence.
As noted previously, it is recommended that ACHD 
patients are provided with psychosocial screening 
accompanied by face to face clinical interviews [29, 
30]. Resources to achieve this goal are currently not 
available in most ACHD centers in high-income coun-
tries. Therefore, identifying the higher risk patients 
may help inform the attending clinicians of their need 
for mental health care.
The challenges previously described for this specific 
ACHD population warrant specialised mental health 
care, especially considering that under-diagnosis and 
under-treatment of psychosocial concerns are present. 
Since resources in healthcare are limited and special-
ised psychosocial care is still not a standard practice 
for ACHD, being able to identify patients’ character-
istics which are linked to psychosocial distress and a 
poor quality of life is of importance. More specifi-
cally, as suggested, it may be helpful to include psy-
chologists during multidisciplinary medical meetings, 
organise specific and periodic psychosocial meetings 
in paediatric and adult cardiology and cardiac surgery 
units and if there are the available resources, screen all 
patients for psychosocial issues with the use of perti-
nent questionnaires and clinical interviews. [29, 31].
Limitations
Although this is largest study of its kind, a few limita-
tions must be acknowledged. First of all, causality can-
not be determined because this is a cross-sectional study. 
Secondly, the patients included in the study are all being 
followed in CHD programs and therefore the results 
may not be generalizable to patients who are not being 
followed in CHD programs in participating countries. 
Thirdly, the patients who were not physically or mentally 
capable of completing the questionnaire are not captured 
by the study. Fourthly, it is not possible to determine 
the totality of possible factors that could impact on the 
PROs, such as undiagnosed syndromes or family history 
of mental problems. Finally, 260 patients could not be 
included in the analysis due to missing data.
Conclusions
In this study it was reported that the majority of patients 
with CHD (i.e., clusters 1 and 2; 89.6%) have a good qual-
ity of life and are reasonably satisfied with their lives. 
They generally have a good health perception and psy-
chological functioning when it comes to anxiety and 
depression. A minority of patients (i.e., 10.4%) fared less 
well on these constructs and had the following demo-
graphic and medical characteristics; higher percentage 
of females, more complex CHD, older age, lower level 
of education, more cardiac comorbidities (i.e., conges-
tive heart failure, arrhythmias, and implanted cardiac 
devices, greater number of cardiac operations and cath-
eterization), and more hospitalizations in the preceding 
year. Knowledge of these patient characteristics may help 
inform screening programs to identify and manage psy-
chosocial difficulties in this population so as to provide 
timely interventions whenever possible.
Ethical issues
The overarching study protocol was approved by the 
Institutional Review Board of the University Hospitals 
Leuven/KU Leuven (i.e., the coordinating center). Addi-
tionally, ethical approval was obtained by each participat-
ing center, if required. Although informed consent  was 
obtained from all participants in most centers, there are 
some countries in which national legislation stipulates 
that written consent for survey studies is not required. 
Maintaining participant confidentiality is deemed a high 
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medical record number, or date of birth) is sent from the 
participating centers to the coordinating center. A unique 
patient study identification code consists of a two-digit 
center identification code followed by a three-digit 
patient identification number. For example, code 01–001 
represents the first patient recruited from the first 
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participating center. APPROACH-IS follows the recom-
mendations of the Declaration of Helsinki. The authors 
of this manuscript have certified that they comply with 
the Principles of Ethical Publishing in the International 
Journal of Cardiology. The study protocol was recorded 
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